According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...

Merilog is the third insulin biosimilar product approved by the FDA and joins the two long-acting insulin biosimilar products ...

A full-year 2024 trading update for Arecor Therapeutics shows revenue was up to £5.1million (2023: £4.6m) while cash and cash ...

(Alliance News) - Arecor Therapeutics PLC on Monday said its revenue increased in 2024 and said it is excited by the prospects of its "superior insulin candidate". The Cambridgeshire, England-based ...

Cambridge biopharma company Arecor saw its cash pile more than halved in the year to December 31; it was down from £6.8 ...

Everything happens fast, with no waiting or lag, not even for the shutter to snap in the camera. Performance is outstanding. With the same battery size as last year’s S24 Ultra, the new phone ...

I’ve also noticed that the S25 Ultra’s fast charging over USB-C works pretty well, regaining 50% of its charge in 45 minutes. And that’s without turning Airplane mode on, so it was actively ...

The rapid-acting treatment is approved for the acute treatment of migraine episodes regardless of whether they are accompanied by aura, which are the sensory disturbances—mostly visual—that ...